Dr. Allison Betof Warner from Stanford University joins Rahul Gosain, MD and Rohit Gosain, MD, on the Oncology Brothers podcast to discuss melanoma treatment. The conversation covers the standard of care for various stages, including the importance of neo-adjuvant therapy, especially for stage 3 melanoma. They touch on the evolving role of immunotherapy and targeted therapy, including the NADINA trial results. The discussion also highlights the approval of tumor-infiltrating lymphocytes (TILs) for PD-1 refractory melanoma, emphasizing the importance of clinical trials in advancing treatment options. The podcast offers insights on managing metastatic melanoma and the need for collaboration with tertiary centers.